Title : Plasma cytokeratin-18 concentrations as noninvasive biomarker of early gastrointestinal toxicosis in dogs receiving toceranib.

Pub. Date : 2018 Nov

PMID : 30353992






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 HYPOTHESIS/OBJECTIVE: To assess if changes in plasma cytokeratin 18 (CK18) concentration, measured in dogs being treated with toceranib phosphate, can predict the onset of GI toxicosis. toceranib phosphate keratin 18 Canis lupus familiaris
2 HYPOTHESIS/OBJECTIVE: To assess if changes in plasma cytokeratin 18 (CK18) concentration, measured in dogs being treated with toceranib phosphate, can predict the onset of GI toxicosis. toceranib phosphate keratin 18 Canis lupus familiaris
3 We hypothesize that an increase in CK18 concentrations will be detected before the development of GI toxicosis in dogs treated with toceranib phosphate. toceranib phosphate keratin 18 Canis lupus familiaris